stockrow
Friday 6 November 2026
Export BIOX’s income statement to Excel — free account
Bioceres Crop Solutions Corp.
BIOX Basic Materials Agricultural Inputs
Bioceres Crop Solutions Corp.’s revenue for fiscal 2026 (year ended June 2026) was $238.2 million, down 28.6% from fiscal 2025.
- Revenue
- −34.7%
- EPS
- −700.0%
- Free cash flow
- +344.3%
- Total debt
- −29.7%
Quarter to March 2026, against a year earlier
0.24
0.03
+14.29%
Follow BIOX
Alert me
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 3 | 4 | 3 |
+8 more TTM periods Free account |
| 0.00% | (105.78%) | (17.77%) | (17.14%) | ||
| (37.24%) | (34.33%) | (7.22%) | (6.86%) | ||
ROIC |
(2.94%) | (1.21%) | 0.40% | (0.33%) | |
Return on Tangible Assets |
(1,065.75%) | (896.25%) | (98.08%) | (123.42%) | |
Average Days of Receivables |
202.97 | 215.25 | 203.51 | 200.89 | |
Free Cash Flow per Share |
0.00 | 1.24 | 0.85 | 0.70 | |
Free Cash Flow |
— | 78.53 | 53.97 | 44.30 | |
Capital Expenditures |
— | (3.34) | (5.16) | (5.60) | |
| Other line items | |||||
Cash ROIC |
0.00% | 32.26% | 12.16% | 9.08% | |
Accounts Receivable Turnover |
1.52 | 1.40 | 1.60 | 1.63 | |
Accounts Payable Turnover |
1.62 | 1.53 | 1.54 | 1.53 | |
Inventory Turnover |
2.31 | 2.06 | 1.80 | 1.88 | |
Average Days of Payables |
172.14 | 182.50 | 185.76 | 173.03 | |
Days of Inventory on Hand |
114.18 | 137.07 | 175.84 | 161.47 | |
Tax Rate |
0.10 | 0.11 | 0.08 | 0.02 | |
Research and Development Expense of Revenue |
0.00% | 5.69% | 5.12% | 4.47% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 36.95% | 36.62% | 36.91% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 1.13% | 1.32% | |
Interest Coverage |
(0.15) | (0.07) | 0.04 | (0.04) | |
Operating CF/Net income |
0.00 | (0.34) | (1.05) | (0.90) | |
Depreciation/Fixed assets |
0.00 | 0.37 | 0.31 | 0.30 | |
Capex/Depreciation |
— | (0.15) | (0.23) | (0.25) | |
Revenue per Share |
4.26 | 4.60 | 5.00 | 5.28 | |
Operating CF per Share |
0.00 | 1.29 | 0.93 | 0.79 | |
Capex per Share |
0.00 | (0.05) | (0.08) | (0.09) | |
Capex to Sales |
0.00 | 0.01 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 6 Nov 2026